Downstream synthetic route of 50901-46-7

50901-46-7, 50901-46-7 1-(Pyridazin-4-yl)ethanone 14452005, apyridazine compound, is more and more widely used in various fields.

With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.50901-46-7,1-(Pyridazin-4-yl)ethanone,as a common compound, the synthetic route is as follows.

To a mixture of ethyl 2,2,2-trifluoroacetate (0.256 g) and sodium methoxide (25% by wt in methanol, 0.449 mL) in tert- butyl methyl ether (0.409 mL) was added a suspension of 1-pyridazin-4-ylethanone (0.200 g) in tert- butyl methyl ether (2.87 mL) at room temperature and the mixture stirred at room temperature overnight. The reaction mixture was adjusted to pH 4 with 10% aqueous citric acid solution, diluted with water and extracted with dichloromethane (x3). Both liquid phases were concentrated, combined, then purified by preparative reverse phase HPLC to afford 4,4,4-trifluoro-1- pyridazin-4-yl-butane-1 ,3-dione as a brown gum. The product was a 2: 1 mixture of the enofketo tautomers. (0765) 1 H NMR (400MHz, CDsCN) (0766) peaks for keto tautomer 9.57 (s, 1 H) 9.51-9.43 (m, 1 H) 8.04-7.98 (m, 1 H) 3.52 (s, 2H) (0767) peaks for enol tautomer (shown below) 9.64 (s, 1 H) 9.5-9.44 (m, 1 H) 8.10-8.04 (m, 1 H) 6.96 (s, 1 H)

50901-46-7, 50901-46-7 1-(Pyridazin-4-yl)ethanone 14452005, apyridazine compound, is more and more widely used in various fields.

Reference£º
Patent; SYNGENTA PARTICIPATIONS AG; SCUTT, James, Nicholas; WILLETTS, Nigel, James; SONAWANE, Ravindra; PHADTE, Mangala; KANDUKURI, Sandeep, Reddy; SASMAL, Swarnendu; ARMSTRONG, Sarah; MCGRANAGHAN, Andrea; (155 pag.)WO2019/185875; (2019); A1;,
Pyridazine – Wikipedia
Pyridazine | C4H4N2 – PubChem